Phosphatidylinositol-3-kinase inhibitor and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SUZHOU UNIV
- Publication Date
- 2010-10-06
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of drugs for treating tumors, and in particular relates to a phosphatidylinositol-3-kinase inhibitor and its application as an anti-tumor drug. Background technique
[0002] Due to various reasons, the incidence of tumors has been increasing year by year. Statistics show that cancer has become the number one cause of death. In terms of tumor drugs, in 2005, the global sales of anti-cancer drugs totaled 28.2 billion US dollars, while the sales of anti-cancer drugs in my country are also increasing at an annual rate of 15% to 17%. , with an annual growth rate of more than 30%. Unfortunately, most of the antineoplastic drugs currently on the market are controlled by developed countries such as the United Kingdom and the United States, so actively developing new drugs with independent intellectual property rights has a very broad prospect.
[0003] The phosphatidylinositol 3-kinase (PI3K) signaling pathway is the main s...